Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Altavilla

Showing results (31-40 of 102) with videos related to

Pageof 11
Sort By:
Dermatologic Therapy|October 17, 2020
Radiation recall during cemiplimab therapy for locally advanced cutaneous squamous cell carcinomaMario Vaccaro, Lucrezia Bertino, Mariacarmela Santarpia, et al.
Journal of Neuro-Oncology|January 25, 2007
Salvage therapy for primary central nervous system lymphoma with (90)Y-Ibritumomab and TemozolomideVincenzo Pitini, Sergio Baldari, Giuseppe Altavilla, et al.
British Journal of Haematology|March 17, 2010
HCV genotype 2 as a risk factor for reactivation in patients with B-cell lymphoma undergoing rituximab combination chemotherapyVincenzo Pitini, Giuseppe Sturniolo, Carmela Arrigo, et al.
Archives of Endocrinology and Metabolism|July 9, 2015
Thyroid function, autoimmunity and nodules in hematological malignanciesPatrizia Mondello, Alessandro Sindoni, Vincenzo Pitini, et al.
Springerplus|April 9, 2014
Necrotizing fasciitis as a rare complication of osteonecrosis of the jaw in a patient with multiple myeloma treated with lenalidomide: case report and review of the literaturePatrizia Mondello, Vincenzo Pitini, Carmela Arrigo, et al.
Future Oncology (London, England)|March 9, 2013
Moving towards molecular-guided treatments: erlotinib and clinical outcomes in non-small-cell lung cancer patientsMariacarmela Santarpia, Tommaso Martino De Pas, Giuseppe Altavilla, et al.
Translational Lung Cancer Research|February 2, 2019
Temozolomide in combination with either veliparib or placebo in patients with relapsed-sensitive or refractory small-cell lung cancerChiara Lazzari, Vanesa Gregorc, Alessandra Bulotta, et al.
Acta Oto-Laryngologica|October 30, 2009
Expression of p53, p16INK4A, pRb, p21WAF1/CIP1, p27KIP1, cyclin D1, Ki-67 and HPV DNA in sinonasal endophytic Schneiderian (inverted) papillomaGiuseppe Altavilla, Alberto Staffieri, Graziella Busatto, et al.
Epigenomics|August 2, 2016
Recent advances in epigenomics in NSCLC: real-time detection and therapeutic implicationsAntonello Di Paolo, Marzia Del Re, Iacopo Petrini, et al.
Haematologica|August 23, 2006
Pitfalls of positron emission tomography for assessing relapse in Hodgkin's disease: a case reportVincenzo Pitini, Giuseppe Navarra, Vittorio Cavallari, et al.
Pageof 11

Showing results (31-40 of 102) with videos related to

Sort By:
Pageof 11
Dermatologic Therapy|October 17, 2020
Radiation recall during cemiplimab therapy for locally advanced cutaneous squamous cell carcinomaMario Vaccaro, Lucrezia Bertino, Mariacarmela Santarpia, et al.
Journal of Neuro-Oncology|January 25, 2007
Salvage therapy for primary central nervous system lymphoma with (90)Y-Ibritumomab and TemozolomideVincenzo Pitini, Sergio Baldari, Giuseppe Altavilla, et al.
British Journal of Haematology|March 17, 2010
HCV genotype 2 as a risk factor for reactivation in patients with B-cell lymphoma undergoing rituximab combination chemotherapyVincenzo Pitini, Giuseppe Sturniolo, Carmela Arrigo, et al.
Archives of Endocrinology and Metabolism|July 9, 2015
Thyroid function, autoimmunity and nodules in hematological malignanciesPatrizia Mondello, Alessandro Sindoni, Vincenzo Pitini, et al.
Springerplus|April 9, 2014
Necrotizing fasciitis as a rare complication of osteonecrosis of the jaw in a patient with multiple myeloma treated with lenalidomide: case report and review of the literaturePatrizia Mondello, Vincenzo Pitini, Carmela Arrigo, et al.
Future Oncology (London, England)|March 9, 2013
Moving towards molecular-guided treatments: erlotinib and clinical outcomes in non-small-cell lung cancer patientsMariacarmela Santarpia, Tommaso Martino De Pas, Giuseppe Altavilla, et al.
Translational Lung Cancer Research|February 2, 2019
Temozolomide in combination with either veliparib or placebo in patients with relapsed-sensitive or refractory small-cell lung cancerChiara Lazzari, Vanesa Gregorc, Alessandra Bulotta, et al.
Acta Oto-Laryngologica|October 30, 2009
Expression of p53, p16INK4A, pRb, p21WAF1/CIP1, p27KIP1, cyclin D1, Ki-67 and HPV DNA in sinonasal endophytic Schneiderian (inverted) papillomaGiuseppe Altavilla, Alberto Staffieri, Graziella Busatto, et al.
Epigenomics|August 2, 2016
Recent advances in epigenomics in NSCLC: real-time detection and therapeutic implicationsAntonello Di Paolo, Marzia Del Re, Iacopo Petrini, et al.
Haematologica|August 23, 2006
Pitfalls of positron emission tomography for assessing relapse in Hodgkin's disease: a case reportVincenzo Pitini, Giuseppe Navarra, Vittorio Cavallari, et al.
Pageof 11